Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients

Patricia C Salgado1 Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo

Fabiana DV Genvigir1 Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao PauloCorrespondence[email protected]

Claudia R Felipe2 Division of Nephrology, Hospital do Rim, Federal University of Sao Paulo, Sao Paulo, Brazil

Helio Tedesco-Silva Jr2 Division of Nephrology, Hospital do Rim, Federal University of Sao Paulo, Sao Paulo, Brazil

Jose O Medina-Pestana2 Division of Nephrology, Hospital do Rim, Federal University of Sao Paulo, Sao Paulo, Brazil

Sonia Q Doi3 School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA

Mario H Hirata1 Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo

Rosario DC Hirata1 Department of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of Sao Paulo

show all

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date